Experienced in Hypercalcemia

Dr. Rodolfo J. Galindo

Endocrinology
University Of Miami
1475 Nw 12th Ave 1st Fl, Umhc Sccc, 
Miami, FL 
Experienced in Hypercalcemia
University Of Miami
1475 Nw 12th Ave 1st Fl, Umhc Sccc, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rodolfo Galindo is an Endocrinologist in Miami, Florida. Dr. Galindo is rated as an Experienced provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Diabetic Ketoacidosis, Type 2 Diabetes (T2D), End-Stage Renal Disease (ESRD), Pancreaticoduodenectomy, and Pancreatectomy.

His clinical research consists of co-authoring 116 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hypercalcemia.

Specialties
Endocrinology
Licenses
Internal Medicine in FL
Hospital Affiliations
Jackson Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UNIVERSITY OF MIAMI
1475 Nw 12th Ave 1st Fl, Umhc Sccc, Miami, FL 33136

Additional Areas of Focus

Dr. Galindo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
A Randomized, Open-Label, Parallel-Group, Two-Arm, Phase 4 Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared With Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Phase: Phase 4
Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)
Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)
Enrollment Status: Completed
Publish Date: February 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)
Enrollment Status: Completed
Publish Date: April 08, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

116 Total Publications

Wearable Diabetes Technology for Hospitalized People With Diabetes and End-Stage Kidney Disease, Peripartum State, and Steroid Use.
Wearable Diabetes Technology for Hospitalized People With Diabetes and End-Stage Kidney Disease, Peripartum State, and Steroid Use.
Journal: Journal of diabetes science and technology
Published: September 03, 2025
Similar Doctors
Distinguished in Hypercalcemia
Dr. David Levenson
Endocrinology | Geriatrics
Distinguished in Hypercalcemia
Dr. David Levenson
Endocrinology | Geriatrics

New York University

16244 S Military Trl, 560 Nyu Langone Cardiology, 
Delray Beach, FL 
 (45.1 miles away)
561-495-7787
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Levenson is an Endocrinologist and a Geriatrics provider in Delray Beach, Florida. Dr. Levenson is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hyperparathyroidism, and Idiopathic Hypercalciuria.

Distinguished in Hypercalcemia
Dr. Ihosvani Miguel
Endocrinology
Distinguished in Hypercalcemia
Dr. Ihosvani Miguel
Endocrinology
500 Se 17th St, Suite 301, 
Fort Lauderdale, FL 
 (22.0 miles away)
855-844-1545
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ihosvani Miguel is an Endocrinologist in Fort Lauderdale, Florida. Dr. Miguel is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. His top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Familial Hypocalciuric Hypercalcemia Type 1, and Idiopathic Hypercalciuria.

Advanced in Hypercalcemia
Dr. Irina Robinson
Endocrinology
Advanced in Hypercalcemia
Dr. Irina Robinson
Endocrinology

East Coast Medical Associates, Inc.

1500 Nw 10th Ave, Suite 205, 
Boca Raton, FL 
 (40.3 miles away)
561-391-1085
Languages Spoken:
English
See accepted insurances

Irina Robinson is an Endocrinologist in Boca Raton, Florida. Dr. Robinson is rated as a Distinguished provider by MediFind in the treatment of Hypercalcemia. Her top areas of expertise are Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hypercalcemia, and Milk-Alkali Syndrome.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Galindo's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile